Skip to main content

Covista Inc.

corporate_fare Company Profile

Covista Inc.

ATGE·NYSE·Consumer Defensive·CIK 0000730464

Adtalem Global Education Inc. is a leading healthcare educator in the U.S., incorporated in Delaware in August 1987. The company prepares a diverse talent workforce for the healthcare industry. Adtalem operates five institutions focusing on healthcare programs, including nursing, social and behavioral sciences, medicine, and veterinary medicine. These institutions are Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. Together, these institutions serve more than 90,000 students across multiple campuses and online, and have an alumni community of approximately 350,000. Adtalem delivers highly qualified healthcare clinicians to urban and rural communities as a scaled provider of workers to the U.S. healthcare system. The company offers responsive educational programs supported by student services. Adtalem has one reportable segment: Chamberlain, which includes the operations of Chamberlain University, offering degree and certificate programs in the nursing and health professions postsecondary education industry.

Covista Inc. (NYSE:ATGE) is a publicly traded company in the Consumer Defensive sector. Wiseek monitors ATGE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Covista Unveils "Purpose at Scale" Strategy and Strong Long-Term Financial Targets at Investor Day
  • Covista Inc. Rebrands from Adtalem Global Education, Changes Ticker to CVSA, and Announces Strategic Investor Day
  • Adtalem Reports Strong Q2 FY26 Adjusted Earnings, Authorizes $750M Share Repurchase
  • Adtalem Reports Strong Q2 FY26 Results, Raises EPS Guidance, and Authorizes $750M Share Buyback
Browse all tickers starting with A →
$98.54
Market cap
$3.4B
Volume
683.1K (1.4× avg)
3-mo avg 478.7K
Live data · 2026-06-14 05:15 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ATGE - Latest Insights

ATGE
Feb 24, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $98.54
Real-time Price: $98.54 info
Change: $0 (0%) info
Market Cap: $3.4B info
ATGE
Feb 06, 2026, 5:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $104.48
Real-time Price: $98.54 info
Change: -$5.94 (-6%) info
Market Cap: $3.4B info
ATGE
Jan 28, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $118.00
Real-time Price: $98.54 info
Change: -$19.46 (-16%) info
Market Cap: $3.4B info
ATGE
Jan 28, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $118.00
Real-time Price: $98.54 info
Change: -$19.46 (-16%) info
Market Cap: $3.4B info